PROFECTUS BIOSCIENCES – Profectus BioSciences, Inc. has received a contract from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) aimed at accelerating the advancement of the company’s candidate Ebola vaccine into human clinical studies. In previous preclinical studies conducted in collaboration with the National Institutes of Health (NIH) and Department of Defense (DoD) in non-human primates, a single dose of the Profectus vaccine has been shown to provide 100% protection against Ebola Zaire. Continue Reading